Hematopoietic stem cell McAllister's 1997
Since McAllister's 1997
report on a patient with multiple sclerosis (MS) who received a bone
marrow transplant for CML, there have been over 600 reports of HSCTs
performed primarily for MS. These have been shown to
"reduce or eliminate ongoing clinical relapses, halt further
progression, and reduce the burden of disability in some patients" that
have aggressive highly active multiple sclerosis, "in the absence of
chronic treatment with disease-modifying agents".
No comments:
Post a Comment